Growth factor therapy and autologous lymph node transfer in lymphedema

Circulation

Volumn 123, Issue 6, 2011, Pages 613-620

  Lähteenvuo, Markku ^a   Honkonen, Krista ^a   Tervala, Tomi ^b   Tammela, Tuomas ^c   Suominen, Erkki ^b   Lähteenvuo, Johanna ^a   Kholová, Ivana ^a   Alitalo, Kari ^c   Ylä Herttuala, Seppo ^a   Saaristo, Anne ^b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

lymphangiogenesis; lymphatic vessels; vascular endothelial growth factor C; vascular endothelial growth factor D

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; VASCULOTROPIN C; VASCULOTROPIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS LYMPH NODE TRANSFER; AUTOTRANSPLANTATION; CONTROLLED STUDY; INGUINAL LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; NONHUMAN; PRIORITY JOURNAL; SEROMA; SWINE; THERAPY EFFECT; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRUSES, HUMAN; ANIMALS; BETA-GALACTOSIDASE; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; LYMPH NODES; LYMPHEDEMA; SEROMA; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 79951682042     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.965384     Document Type: Article

References (32)

1. Witte MH, Witte CL. Lymphatics and blood vessels, lymphangiogenesis and hemangiogenesis: from cell biology to clinical medicine. Lymphology. 1987;20:257-266. (Pubitemid 18087355)
2. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140:460-476.
3. Baumeister RG, Seifert J, Hahn D. Autotransplantation of lymphatic vessels. Lancet. 1981;1:147.
4. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28:609-613. (Pubitemid 38802800)
5. Nagase T, Gonda K, Inoue K, Higashino T, Fukuda N, Gorai K, Mihara M, Nakanishi M, Koshima I. Treatment of lymphedema with lymphati-covenular anastomoses. Int J Clin Oncol. 2005;10:304-310.
6. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243:313-315. (Pubitemid 43327760)
7. Oliver G. Lymphatic vasculature development. Nat Rev Immunol. 2004; 4:35-45. (Pubitemid 38084130)
8. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438:967-974. (Pubitemid 43093963)
9. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997;16: 3898-3911. (Pubitemid 27281006)
10. Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA. 1998;95:548-553. (Pubitemid 28083780)
11. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem. 1999; 274:32127-32136.
12. Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Ylä-Herttuala S, Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med. 2002;196:719-730.
13. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivelä A, Hedman A, Hedman M, Heikura T, Ordén MR, Stacker SA, Achen MG, Hartikainen J, Ylä-Herttuala S. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endo-thelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation. 2004;109:1029-1035. (Pubitemid 38282857)
14. Anisimov A, Alitalo A, Korpisalo P, Soronen J, Kaijalainen S, Leppänen VM, Jeltsch M, Ylä-Herttuala S, Alitalo K. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res. 2009;104:1302-1312.
15. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA. 2001;98:12677-12682. (Pubitemid 33020005)
16. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002;16:1985-1987.
17. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003;111:717-725. (Pubitemid 36278590)
18. Saaristo A, Tammela T, Timonen J, Yla-Herttuala S, Tukiainen E, Asko-Seljavaara S, Alitalo K. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 2004; 18:1707-1709. (Pubitemid 39561658)
19. Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-Ramadan U, Ylä-Herttuala S, Petrova TV, Alitalo K. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med. 2007;13:1458-1466. (Pubitemid 350224251)
20. Mebius RE, Streeter PR, Brevé J, Duijvestijn AM, Kraal G. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol. 1991;115:85-95. (Pubitemid 21909896)
21. Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M, Kossila M, Häkkinen TP, Kivelä A, Enholm B, Mansukoski H, Turunen AM, Alitalo K, Ylä-Herttuala S. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neoin-tima formation in balloon-denuded rabbit aorta. Circulation. 2000;102: 2262-2268.
22. Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, Pakkanen T, Luoma JS, Viita H, Hartikainen J, Alhava E, Laakso M, Ylä-Herttuala S. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther. 1998;9: 1481-1486. (Pubitemid 28379087)
23. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286:2511-2514.
24. Leppänen V-M, Jeltsch M, Anisimov A, Tvorogov D, Aho K, Kalkkinen N, Toivanen P, Ylä-Herttuala S, Ballmer-Hofer K, Alitalo A. Structural determinants of vascular endothelial growth factor-D-receptor binding and specificity. Blood. December 8, 2010. DOI: 10.1182/blood-2010-08-301549. Available at: http://bloodjournal.hematologylibrary.org.
25. Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, An A, Rockson SG. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006;20:363-370. (Pubitemid 46089663)
26. Shin WS, Rockson SG. Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci. 2008;1131: 50-74. (Pubitemid 351758503)
27. Baker A, Kim H, Semple JL, Dumont D, Shoichet M, Tobbia D, Johnston M. Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy. Breast Cancer Res. September 8, 2010. DOI:10.1186/bcr2638. Available at: http://breast-cancer- research.com/content/12/5/R70.
28. Hadamitzky C, Pabst R. Acquired lymphedema: an urgent need for adequate animal models. Cancer Res. 2008;68:343-345. (Pubitemid 351380058)
29. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198. (Pubitemid 32148486)
30. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201:1089-1099. (Pubitemid 40524677)
31. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109:1010-1017. (Pubitemid 46220646)
32. Hirakawa S, Detmar M, Kerjaschki D, Nagamatsu S, Matsuo K, Tanemura A, Kamata N, Higashikawa K, Okazaki H, Kameda K, Nishida-Fukuda H, Mori H, Hanakawa Y, Sayama K, Shirakata Y, Tohyama M, Tokumaru S, Katayama I, Hashimoto K. Nodal lymphangio-genesis and metastasis: role of tumor-induced lymphatic vessel activation in extramammary Paget's disease. Am J Pathol. 2009;175:2235-2248.